SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI
CCSI 28.71-2.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: baggo who wrote (2253)5/22/1998 11:33:00 PM
From: Cacaito  Read Replies (2) of 5736
 
Brice,

I am not questioning the Colormate ability to measure bilirubin.

I am not questioning the company ability to sell the product.

But, most pediatricians will not need the Colormate.

Newborn units are the main market.

For liver disorders the product add nothing to the evaluation of a patient.

Of course, the product is highly welcome by pediatricians.

Will a pediatric surgeon trust ONLY the Colormate bilirubin test for the evaluation of a 4 week old baby with a differential diagnosis between billiary atresia vs a hemolytic disorder? NO

This limitation of the Colormate will not hampered the intended market (less than one week old newborns), but forget the rest of the bilirubin testing market it is useless, it adds nothing to the evaluation of a patient, it just repeat information obtained with the eyes, either your are yellow or you are not.

SPRX will compete again CCSI in the near future in the USA.

SPRX is shipping product to the international market (or they are not telling the truth in their press releases).

Please, do not answer if it is for senseless insults. I respect whatever amount of patient you have. I am not in the business of bickering.

I decided to check this company after I saw their product in New Orleans, I wish to have known of it 1 year ago, now I am evaluating if it is still a good buy or not.

I am not shorting a company that will have a commercial launch (and that I expect it to be a great success) but I will always try to see the growth of the company sales in a conservative way.

My native language is Spanish, oxygen spelling is very similar to the English one but with an I not Y. Sorry, SI did not alert for that word misspelling.

My inquiry about sugar testing was genuine, since similar technologies are already under development.

Someone call my "business model" a joke, no problem, at least provide with a counterpart one, it will be a service to other readers (or to me). One should not wait for the analysts to provide a business model soon, by that time most of the stock future appreciation will be out of grasp(if any).

Did you know that the intended price of the Colormate will be in the $3000 range before I post it? Well, maybe you did, but other readers did not.

Actually, I also asked to the Colormate people at the New Orleans boost the price of the disposables (I do not remember but it was about $1o to $15 each, sell in small boxes of 50?).

I did forgot to included the disposables in my now infamous "business model" Well, that is one of the functions of SI, to exchange information until the best and closer to the facts is out.

Respectfully,

cacaito
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext